Literature DB >> 22398157

Exhaled breath condensate collection in the mechanically ventilated patient.

Stewart R Carter1, Christopher S Davis, Elizabeth J Kovacs.   

Abstract

Collection of exhaled breath condensate (EBC) is a non-invasive means of sampling the airway-lining fluid of the lungs. EBC contains numerous measurable mediators, whose analysis could change the management of patients with certain pulmonary diseases. While initially popularized in investigations involving spontaneously breathing patients, an increasing number of studies have been performed using EBC in association with mechanical ventilation. Collection of EBC in mechanically ventilated patients follows basic principles of condensation, but is influenced by multiple factors. Effective collection requires selection of a collection device, adequate minute ventilation, low cooling temperatures, and sampling times of greater than 10 min. Condensate can be contaminated by saliva, which needs to be filtered. Dilution of samples occurs secondary to distilled water in vapors and humidification in the ventilator circuit. Dilution factors may need to be employed when investigating non-volatile biomarkers. Storage and analysis should occur promptly at -70 °C to -80 °C to prevent rapid degradation of samples. The purpose of this review is to examine and describe methodologies and problems of EBC collection in mechanically ventilated patients. A straightforward and safe framework has been established to investigate disease processes in this population, yet technical aspects of EBC collection still exist that prevent clinical practicality of this technology. These include a lack of standardization of procedure and analysis of biomarkers, and of normal reference ranges for mediators in healthy individuals. Once these procedural aspects have been addressed, EBC could serve as a non-invasive alternative to invasive evaluation of lungs in mechanically ventilated patients.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398157      PMCID: PMC3314159          DOI: 10.1016/j.rmed.2012.02.003

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  47 in total

1.  Dilution of respiratory solutes in exhaled condensates.

Authors:  Richard M Effros; Kelly W Hoagland; Mark Bosbous; Daniel Castillo; Bradley Foss; Marshall Dunning; Meir Gare; Wen Lin; Feng Sun
Journal:  Am J Respir Crit Care Med       Date:  2002-03-01       Impact factor: 21.405

Review 2.  Collection and analysis of exhaled breath condensate in humans.

Authors:  G M Mutlu; K W Garey; R A Robbins; L H Danziger; I Rubinstein
Journal:  Am J Respir Crit Care Med       Date:  2001-09-01       Impact factor: 21.405

Review 3.  Exhaled markers of pulmonary disease.

Authors:  S A Kharitonov; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

4.  A simple method for estimating respiratory solute dilution in exhaled breath condensates.

Authors:  Richard M Effros; Julie Biller; Bradley Foss; Kelly Hoagland; Marshall B Dunning; Daniel Castillo; Mark Bosbous; Feng Sun; Reza Shaker
Journal:  Am J Respir Crit Care Med       Date:  2003-09-25       Impact factor: 21.405

Review 5.  Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease.

Authors:  John Hunt
Journal:  J Allergy Clin Immunol       Date:  2002-07       Impact factor: 10.793

6.  Exhaled breath condensate acidification in acute lung injury.

Authors:  Christian Gessner; Stefan Hammerschmidt; Hartmut Kuhn; Hans-Jürgen Seyfarth; Ulrich Sack; Lothar Engelmann; Joachim Schauer; Hubert Wirtz
Journal:  Respir Med       Date:  2003-11       Impact factor: 3.415

7.  Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery.

Authors:  Edward D Moloney; Sharon E Mumby; Reka Gajdocsi; Julius H Cranshaw; Sergei A Kharitonov; Gregory J Quinlan; Mark J Griffiths
Journal:  Am J Respir Crit Care Med       Date:  2003-10-09       Impact factor: 21.405

8.  Factors influencing breath condensate volume.

Authors:  C Gessner; H Kuhn; H J Seyfarth; H Pankau; J Winkler; J Schauer; H Wirtz
Journal:  Pneumologie       Date:  2001-09

Review 9.  Markers of pulmonary diseases in exhaled breath condensate.

Authors:  Adam Antczak; Pawel Górski
Journal:  Int J Occup Med Environ Health       Date:  2002       Impact factor: 1.843

10.  Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury.

Authors:  Christian Gessner; Stefan Hammerschmidt; Hartmut Kuhn; Tobias Lange; Lothar Engelmann; Joachim Schauer; Hubert Wirtz
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

View more
  12 in total

Review 1.  Exhaled breath condensate: an overview.

Authors:  Michael D Davis; Alison Montpetit; John Hunt
Journal:  Immunol Allergy Clin North Am       Date:  2012-07-20       Impact factor: 3.479

Review 2.  Exhaled Breath Condensate (EBC): Is It a Viable Source of Biomarkers for Lung Diseases?

Authors:  Stefanos Patsiris; Themis Exarchos; Panayiotis Vlamos
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 3.  Review of non-invasive detection of SARS-CoV-2 and other respiratory pathogens in exhaled breath condensate.

Authors:  Emeka Nwanochie; Jacqueline C Linnes
Journal:  J Breath Res       Date:  2022-03-18       Impact factor: 4.538

4.  Exhaled breath condensate biomarkers in critically ill, mechanically ventilated patients.

Authors:  Michael D Davis; Brett R Winters; Michael C Madden; Joachim D Pleil; Curtis N Sessler; M Ariel Geer Wallace; Cavin K Ward-Caviness; Alison J Montpetit
Journal:  J Breath Res       Date:  2020-11-12       Impact factor: 3.262

Review 5.  Exhaled Breath Condensate: Technical and Diagnostic Aspects.

Authors:  Efstathia M Konstantinidi; Andreas S Lappas; Anna S Tzortzi; Panagiotis K Behrakis
Journal:  ScientificWorldJournal       Date:  2015-05-27

6.  Commentary: Cytokine-Regulation of Na+-K+-Cl- Cotransporter 1 and Cystic Fibrosis Transmembrane Conductance Regulator-Potential Role in Pulmonary Inflammation and Edema Formation.

Authors:  Michael Eisenhut
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

7.  Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate.

Authors:  Charmion Cruickshank-Quinn; Michael Armstrong; Roger Powell; Joe Gomez; Marc Elie; Nichole Reisdorph
Journal:  Respir Res       Date:  2017-04-12

8.  Cytokines and Chemokines Are Detectable in Swivel-Derived Exhaled Breath Condensate (SEBC): A Pilot Study in Mechanically Ventilated Patients.

Authors:  Philip van der Zee; Inez van Walree; Jan-Willem Fijen; Arend-Jan van Houte; Heleen van Velzen-Blad; Ger Rijkers; Diederik Gommers; Henrik Endeman
Journal:  Dis Markers       Date:  2020-01-11       Impact factor: 3.434

Review 9.  Electrochemical sensing: A prognostic tool in the fight against COVID-19.

Authors:  Sharda Kotru; Martin Klimuntowski; Hashim Ridha; Zakir Uddin; Ali A Askhar; Gurmit Singh; Matiar M R Howlader
Journal:  Trends Analyt Chem       Date:  2021-01-23       Impact factor: 14.908

10.  A feasibility study into adenosine triphosphate measurement in exhaled breath condensate: a potential bedside method to monitor alveolar deformation.

Authors:  Philip van der Zee; Peter Somhorst; Jeroen Molinger; Djo Hasan; Diederik Gommers
Journal:  Purinergic Signal       Date:  2018-05-12       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.